{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Global Multicenter, Open Label, Randomized, Phase 3 Registrational Study of Olverembatinib (HQP1351) in Patients with Chronic Phase Chronic Myeloid Leukemia (POLARIS-2)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-global-multicenter-open-label-randomized-phase-3-registrational-study-of-olverembatinib-hqp1351-in-patients-with-chronic-phase-chronic-myeloid-leukemia-polaris-2\/#breadcrumbitem"}]}